Establishment Labs Holdings Inc (ESTA)
52.00
-0.32
(-0.61%)
USD |
NASDAQ |
Apr 18, 10:03
Establishment Labs Holdings Cash from Financing (TTM): 86.23M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 86.23M |
September 30, 2023 | 111.14M |
June 30, 2023 | 111.92M |
March 31, 2023 | 99.74M |
December 31, 2022 | 100.26M |
September 30, 2022 | 75.48M |
June 30, 2022 | 75.86M |
March 31, 2022 | 3.961M |
December 31, 2021 | 4.052M |
September 30, 2021 | 4.383M |
June 30, 2021 | 2.836M |
March 31, 2021 | 2.53M |
December 31, 2020 | 64.67M |
Date | Value |
---|---|
September 30, 2020 | 64.50M |
June 30, 2020 | 86.87M |
March 31, 2020 | 86.73M |
December 31, 2019 | 22.79M |
September 30, 2019 | 22.36M |
June 30, 2019 | 65.18M |
March 31, 2019 | 79.53M |
December 31, 2018 | 81.53M |
September 30, 2018 | 95.25M |
June 30, 2018 | 43.21M |
March 31, 2018 | 29.75M |
December 31, 2017 | 42.99M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
2.53M
Minimum
Mar 2021
111.92M
Maximum
Jun 2023
57.45M
Average
65.18M
Median
Jun 2019
Cash from Financing (TTM) Benchmarks
Ironwood Pharmaceuticals Inc | 277.16M |
Codexis Inc | 8.167M |
Ampio Pharmaceuticals Inc | 0.00 |
Avidity Biosciences Inc | 93.86M |
Kineta Inc | 8.468M |